Novartis Delivered Solid 2016 Performance, Alcon Q4 Sales Flat
Thursday, February 2 2017 | 00 h 00 min | Financial News
Sales were in line with last fiscal year due to strong performances from growth products (Cosentyx, Entresto, Gilenya, oncology, Sandoz...
Read More
Novartis to Acquire Presbyopia Drug Developer Encore Vision
Wednesday, December 21 2016 | 00 h 00 min | Agreements and Acquisitions, News, Press Release
Novartis Ophthalmology announced they have entered into an agreement to acquire a topical treatment for presbyopia from Encore Vision Inc, a...
Read More Novartis on Alcon: All Options are Open
Monday, November 14 2016 | 00 h 00 min | News
Reuters reported yesterday, that Swiss parent of Alcon, drugmaker Novartis is considering the sale of its eye care unit Alcon The source is an...
Read More Alcon Replaces CEO and Restructures After Poor Earnings Report
Thursday, January 28 2016 | 00 h 00 min | News
Following reports of plummeting sales from Alcon’s eye-care unit and news that Novartis will miss its Q4 earnings estimates, Alcon executive Jeff...
Read More Novartis Considering Selling Alcon’s CL Care Business
Wednesday, December 2 2015 | 00 h 00 min | News
Bloomberg News is reporting that Novartis is considering selling Alcon’s contact lens care product business While Alcon’s revenues as a whole...
Read More
